Skip to contentSkip to filters

We use cookies for analytics.

Grant, Call number PAR-25-059

Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Assay Development and Neurotherapeutic Agent Identification (R61/R33 Clinical Trial Not Allowed)

National Institutes of Health

Related content

About

The IGNITE program supports early translational research to identify potential treatments for neurological and neuromuscular disorders. Projects develop assays and screen candidates, with a second phase contingent on milestones.

Topics

Eligibility

Covers: Phased R61/R33 support for assay development, screening and characterization of potential therapeutic agents.

Eligible organizations based outside the US may apply.

simpler.grants.govgrants.nih.gov

Eligible organizations include universities, nonprofit research organizations and other categories specified in the announcement. Eligible organizations based outside the US may apply.

Source: simpler.grants.gov